202 related articles for article (PubMed ID: 30032128)
1. The clinical significance of borderline results of the Elia CTD Screen assay.
Robier C; Amouzadeh-Ghadikolai O
Clin Chem Lab Med; 2018 Nov; 56(12):2088-2092. PubMed ID: 30032128
[TBL] [Abstract][Full Text] [Related]
2. The clinical relevance of anti-dsDNA antibodies determined by the Elia™ dsDNA assay in patients with negative indirect immunofluorescence on the HEp-2 cell.
Robier C; Haas M; Quehenberger F
Clin Chem Lab Med; 2021 Feb; 59(3):541-546. PubMed ID: 33064668
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the clinical utility of the Elia CTD Screen to indirect immunofluorescence on Hep-2 cells.
Robier C; Amouzadeh-Ghadikolai O; Stettin M; Reicht G
Clin Chem Lab Med; 2016 Aug; 54(8):1365-70. PubMed ID: 26677892
[TBL] [Abstract][Full Text] [Related]
4. Low positive rate of serum autoantibodies in colorectal cancer patients without systemic rheumatic diseases.
Fernández-Suárez A; Muñoz-Colmenero A; Ocaña-Pérez E; Fatela-Cantillo D; Domínguez-Jiménez JL; Díaz-Iglesias JM
Autoimmunity; 2016 Sep; 49(6):383-387. PubMed ID: 27424781
[TBL] [Abstract][Full Text] [Related]
5. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
[TBL] [Abstract][Full Text] [Related]
6. Screening for connective tissue disease-associated antibodies by automated immunoassay.
Willems P; De Langhe E; Claessens J; Westhovens R; Van Hoeyveld E; Poesen K; Vanderschueren S; Blockmans D; Bossuyt X
Clin Chem Lab Med; 2018 May; 56(6):909-918. PubMed ID: 29306915
[TBL] [Abstract][Full Text] [Related]
7. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of anti-DFS70 autoantibodies.
Kang SY; Lee WI; Kim MH; La Jeon Y
Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an Automated Screening Assay, Compared to Indirect Immunofluorescence, an Extractable Nuclear Antigen Assay, and a Line Immunoassay in a Large Cohort of Asian Patients with Antinuclear Antibody-Associated Rheumatoid Diseases: A Multicenter Retrospective Study.
Jeong S; Hwang H; Roh J; Shim JE; Kim J; Kim GT; Tag HS; Kim HS
J Immunol Res; 2018; 2018():9094217. PubMed ID: 29854849
[TBL] [Abstract][Full Text] [Related]
10. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening.
González Rodríguez C; Fuentes Cantero S; Pérez Pérez A; Vázquez Barbero FJ; León Justel A
J Clin Lab Anal; 2021 Sep; 35(9):e23914. PubMed ID: 34347308
[TBL] [Abstract][Full Text] [Related]
13. Detection of anti-nuclear antibodies from filter paper blood clots using indirect immunoenzyme technique: preliminary experience and results.
Chopra A; Anuradha V; Edmonds J
J Assoc Physicians India; 2000 May; 48(5):493-6. PubMed ID: 11273141
[TBL] [Abstract][Full Text] [Related]
14. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
Broadfoot A; Sivertsen T; Baumgart K
Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
[TBL] [Abstract][Full Text] [Related]
15. [Performance and clinical evaluation of antinuclear antibody test based on fluorescence enzyme immunoassay].
Watanabe N; Nagatomo R; Okubo S; Yokota H; Ikeda H; Yatomi Y
Rinsho Byori; 2014 Apr; 62(4):315-23. PubMed ID: 25022060
[TBL] [Abstract][Full Text] [Related]
16. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of Indirect immunofluorescence (IIF) alone as a screening method for antinuclear antibody in connective diseases in India's sub-Himalayan region.
Kalita D; Rekha US; Raj AK; Mahanta P; Gupta P; Deka S
Indian J Pathol Microbiol; 2022; 65(4):873-878. PubMed ID: 36308197
[TBL] [Abstract][Full Text] [Related]
18. Measurement of antinuclear antibodies and their fine specificities: time for a change in strategy?
Otten HG; Brummelhuis WJ; Fritsch-Stork R; Leavis HL; Wisse BW; van Laar JM; Derksen RHWM
Clin Exp Rheumatol; 2017; 35(3):462-470. PubMed ID: 28240588
[TBL] [Abstract][Full Text] [Related]
19. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
20. Clinical Aspects of the Dense Fine Speckled Pattern in Indirect Immunofluorescence-Antinuclear Antibody Screening and Its Association with DFS70 Autoantibodies.
La Jeon Y; Kang SY; Lee WI; Kim MH
Ann Clin Lab Sci; 2019 Sep; 49(4):496-502. PubMed ID: 31471339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
